Copy Link Print Information

Agazisiran sodium

Agazisiran sodium, a siRNA,is a complement factor B synthesis reducer.

For research use only. We do not sell to patients.

  • Formula: C534H560F15N179Na46O329P44S8
  • Molecular Weight:17711.00
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Agazisiran sodium Chemical Structure
    Agazisiran sodium Chemical Structure
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Agazisiran sodium Chemical Structure
    Agazisiran sodium Chemical Structure RNA, ([3'-O-[2-[[[1-[17-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-3,6,9,12,15-pentaoxaheptadec-1-yl]-1H-1,2,3-triazol-4-yl]methyl]amino]-2-oxoethyl]-2'-O-[2-[bis[[1-[17-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-3,6,9,12,15-pentaoxaheptadec-1-yl]-1H-1,2,3-triazol-4-yl]methyl]amino]-2-oxoethyl]]U-(5'→5')-sp-Gm-sp-Gm-Am-Am-Gm-Gm-Am-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)U-Gm-Gm-Am-Um-Gm-Um-Cm-Um-sp-Am-(3'→3')-sp-[1'-de(6-amino-9H-purin-9-yl)]A), complex with RNA (Um-sp-(2'-deoxy-2'-fluoro)A-sp-Gm-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)A-Um-(2'-deoxy-2'-fluoro)C-Cm-(2'-deoxy-2'-fluoro)A-Gm-(2'-deoxy-2'-fluoro)A-Um-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)U-Cm-(2'-deoxy-2'-fluoro)C-Um-(2'-deoxy-2'-fluoro)U-sp-Cm-sp-Cm) (1:1), sodium salt
    1/16
  • RNA, ([3'-O-[2-[[[1-[17-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-3,6,9,12,15-pentaoxaheptadec-1-yl]-1H-1,2,3-triazol-4-yl]methyl]amino]-2-oxoethyl]-2'-O-[2-[bis[[1-[17-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-3,6,9,12,15-pentaoxaheptadec-1-yl]-1H-1,2,3-triazol-4-yl]methyl]amino]-2-oxoethyl]]U-(5'→5')-sp-Gm-sp-Gm-Am-Am-Gm-Gm-Am-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)U-Gm-Gm-Am-Um-Gm-Um-Cm-Um-sp-Am-(3'→3')-sp-[1'-de(6-amino-9H-purin-9-yl)]A), complex with RNA (Um-sp-(2'-deoxy-2'-fluoro)A-sp-Gm-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)A-Um-(2'-deoxy-2'-fluoro)C-Cm-(2'-deoxy-2'-fluoro)A-Gm-(2'-deoxy-2'-fluoro)A-Um-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)U-Cm-(2'-deoxy-2'-fluoro)C-Um-(2'-deoxy-2'-fluoro)U-sp-Cm-sp-Cm) (1:1), sodium salt